Etoglucid

This classification denotes an antineoplastic alkylating agent with the molecular formula C12H22O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4F9KUA0T4D, chemically known as 4,7,10,13-tetraoxahexadecane, 1,2:15,16-diepoxy- (8ci) but more generally known as etoglucid, which bears US NIH Compound Identifier 16058. European Medicines Agency schedules Etoglucid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07326MIG. The term ETOGLUCID is an International Non-Proprietary Name. World Health Organization schedules etoglucid in its Anatomical Therapeutic Chemical (ATC) Classification. ETOGLUCID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule etoglucid under HS 29109000 and SITC 51615. As of Q4 2014, ETOGLUCID remains US FDA's Preferred Term for this commodity. Etoglucid bears US NLM identifiers UMLS ID C0015039 and NCI Concept Code C489. SMILES: O1C(C1)COCCOCCOCCOCC1OC1.